Clinical Trial Update: Evaluation of Long-term Efficacy of Treatment With Lamazym [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term efficacy of Lamazym in Alpha-Mannosidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis

Drugs mentioned

• Lamazym

Snippet

Sponsor: Zymenex A/S | Conditions: Alpha-Mannosidosis | Phase 3 | Status: COMPLETED